Drugs / PUR 0110
PUR 0110
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01149694 | Jun → Aug 2009 | ulcerative colitis | PurGenesis Technologies Inc. | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT03540043 | Oct 2017 → Dec 2019 | atopic eczema | PurGenesis Technologies Inc. | Completed | No outcome recorded |
| Phase 2 | NCT01149707 | Jun 2010 → Oct 2014 | proctosigmoiditis, ulcerative colitis | PurGenesis Technologies Inc. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PUR 0110 | “4-Week Multicenter, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Safety and Efficacy Study of Three Concentrations (0.05%, 0.1% and 0.25%) of PUR 0110...” NCT03540043 ↗ |
| Known as | PUR 0110 Rectal Enema | “Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis” NCT01149707 ↗ |
| Known as | Thykamine | “Administration of PUR0110 (Thykamine) 0.05%” NCT03540043 ↗ |
| Route | Rectal | “PUR 0110 rectal enema” NCT01149694 ↗ |